Sample size estimation for cancer randomized trials in the presence of heterogeneous populations
From MaRDI portal
Publication:6055721
DOI10.1111/biom.13527zbMath1520.62182MaRDI QIDQ6055721
Virginie Rondeau, Unnamed Author, Unnamed Author
Publication date: 30 October 2023
Published in: Biometrics (Search for Journal in Brave)
Cites Work
- The shared frailty model and the power for heterogeneity tests in multicenter trials.
- Sample-Size Formula for the Proportional-Hazards Regression Model
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- Estimation of Multivariate Frailty Models Using Penalized Partial Likelihood
- Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints
This page was built for publication: Sample size estimation for cancer randomized trials in the presence of heterogeneous populations